Summary
To evaluate the influence of salt-sensitivity on the plasma insulin and glucose response to infusion of ANP, we studied 22 men with essential hypertension, who were between 40 and 60 years old. After 1 month under normal Na+ intake (120 mmol Na+ per day), patients were randomly assigned to receive either ANP (0.04 μg · kg−1 · min−1) (n=15) or vehicle (50 ml saline) (n=7) over a 60-min period, while in the supine position. Plasma insulin and glucose were measured at time −60, 0, 20, 40, 60, 120, 180, 240 min. Ten days after ANP infusion, blood pressure sensitivity to changes in di etary salt intake was assessed according to a randomized double-blind crossover protocol. Patients were classified into two groups either salt-sensitive (n=8) or salt-resistant (n=7). Our results showed that plasma insulin and glucose did not change during ANP infusion in both groups. However, both plasma insulin (from 75.6 ± 45.1 pmol/l at 60 min to 121.2 ± 48.6 pmol/l at 240 min, p <0.05 vs time 0) and glucose levels (from 4.86 ± 0.73 mmol/l at 60 min to 6.56 ± 1.03 mmol/l at 240 min, p <0.01 vs time 0) rose after discontinuation of ANP in salt-sensitive patients, but did not change at all in salt-resistant patients. In conclusion, this randomized vehicle-controlled study demonstrates that plasma insulin and glucose levels increase in salt-sensitive hypertensive patients after the infusion of ANP. The increase of plasma insulin levels observed after ANP discontinuation, if occurring under physiologic conditions, could influence the blood pressure sensitivity to dietary Na+ intake.
Article PDF
Similar content being viewed by others
Abbreviations
- ANP:
-
Atrial natriuretic peptide
- NIDDM:
-
non-insulin dependent diabetes mellitus
References
Fehmann HC, Noll B, Göke R, Göke B, Trautman ME, Arnold R (1990) Atrial natriuretic factor has a weak insulinotropic action in the isolated perfused rat pancreas. Res Exp Med 190: 253–258
Ahren B (1988) ANF inhibits glucose-stimulated insulin secretion in mouse and rat. Am J Physiol 5: E579-E582
Uehlinger DE, Weidmann P, Gnadinger MP et al. (1986) Increase in circulating insulin induced by atrial natriuretic peptide in normal humans. J Cardiovasc Pharmacol 8: 1122–1129
Weidmann P, Gnädinger MP, Ziswiler HR et al. (1986) Car-diovascular, endocrine and renal effects of atrial natriuretic peptide in essential hypertension. J Hypertens 4[Suppl 2]: 71–83
Haak T, Jungmann E, Hannappel B, Schoffling K (1990) The effect of atrial natriuretic peptide on glucose tolerance and insulin levels. Med Klin 85: 61–64
Ferrari P, Shaw S, Riesen W, Weidmann P (1992) Plasma insulin during physiological and pathophysiological changes in atrial natriuretic factor. Eur J Clin Pharmacol 42: 453–455
Ferri C, De Mattia G, Piccoli A et al. (1991) Plasma insulin levels do not change during atrial natriuretic infusion in human essential hypertensives. Am J Hypertens 4: 880–884
De Mattia G, Tullo O, Ferri C et al. (1990) Atrial natriuretic factor in hypertensive diabetic patients. In: Crepaldi G, Tiengo A, Enzi G (eds) Diabetes, obesity and hyperlipidemias IV. Elsevier Science Publishers B.V.Biomedical Division, Amsterdam, pp 451–453
Mbanya JC, Thomas TH, Taylor R, Baylis P, Wilkinson R, Alberti KGMM (1988) Hypertension and diabetes mellitus: role of insulin and atrial natriuretic peptide. Diabetologia 31: 519 A (Abstract)
Sharma AM, Ruland K, Spies KP, Distler A (1991) Salt-sensitivity in young normotensive subjects is associated with hyperinsulinemic response to oral glucose. J Hypertens 9: 329–335
Leonetti Luparini R, Ferri C, Santucci A, Balsano F (1993) Atrial natriuretic peptide in non-modulating essential hypertension. Hypertension 21: 803–809
Williams RR, Hasstedt SJ, Hunt SC et al. (1991) Genetic traits related to hypertension and electrolyte metabolism. Hypertension 17[Suppl I]: I-69–I-73
Reaven GM, Twersky J, Chang H (1991) Abnormalities of carbohydrate and lipid metabolism in Dahl Rats. Hypertension 18: 630–635
Rocchini AP, Key J, Bondie D et al. (1989) The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescent. N Engl J Med 321: 580–585
Tuck M, Corry D, Trujillo A (1990) Salt-sensitive blood pressure and exaggerated vascular reactivity in the hypertension of diabetes mellitus. Am J Med 88: 210–216
Atlas SA, Laragh JH (1990) Atrial natriuretic factor: its involvement in hypertensive disorders. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis and management, Vol 1. Reaven Press, New York, pp 861–884
Ferrannini E, De Fronzo RA (1989) The association of hypertension, diabetes and obesity: a review. J Nephrol 1: 3–15
Santucci A, Ferri C (1992) Insulin resistance and essential hypertension: pathophysiologic and therapeutic implications. J Hypertens 10[Suppl 2]: S9-S15
Ferri C, De Mattia G, Bellini C et al. (1993) Octreotide, a somatostatin analog, reduces insulin secretion and increases renal Na+ excretion in lean essential hypertensive patients. Am J Hypertens 6: 276–281
Richards AM (1989) Atrial natriuretic factors administered to humans: 1984–1988. J Cardiovasc Pharmacol 13[Suppl 6]: S69-S74
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ferri, C., Bellini, C., Desideri, G. et al. Salt-sensitivity is associated with a hyperinsulinaemic and hyperglycaemic response to atrial natriuretic peptide infusion in human essential hypertension. Diabetologia 37, 308–312 (1994). https://doi.org/10.1007/BF00398059
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00398059